Unknown

Dataset Information

0

Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism.


ABSTRACT: Studies of copy number variation (CNV) have characterized loci and molecular pathways in a range of neuropsychiatric conditions. We analyzed rare CNVs in Tourette syndrome (TS) to identify novel risk regions and relevant pathways, to evaluate burden of structural variation in cases versus controls, and to assess overlap of identified variations with those in other neuropsychiatric syndromes.We conducted a case-control study of 460 individuals with TS, including 148 parent-child trios and 1131 controls. CNV analysis was undertaken using 370 K to 1 M probe arrays, and genotyping data were used to match cases and controls for ancestry. CNVs present in < 1% of the population were evaluated.While there was no significant increase in the number of de novo or transmitted rare CNVs in cases versus controls, pathway analysis using multiple algorithms showed enrichment of genes within histamine receptor (subtypes 1 and 2) signaling pathways (p = 5.8 × 10(-4) - 1.6 × 10(-2)), as well as axon guidance, cell adhesion, nervous system development, and synaptic structure and function processes. Genes mapping within rare CNVs in TS showed significant overlap with those previously identified in autism spectrum disorders but not intellectual disability or schizophrenia. Three large, likely pathogenic, de novo events were identified, including one disrupting multiple gamma-aminobutyric acid receptor genes.We identify further evidence supporting recent findings regarding the involvement of histaminergic and gamma-aminobutyric acidergic mechanisms in the etiology of TS and show an overlap of rare CNVs in TS and autism spectrum disorders.

SUBMITTER: Fernandez TV 

PROVIDER: S-EPMC3282144 | biostudies-literature | 2012 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Studies of copy number variation (CNV) have characterized loci and molecular pathways in a range of neuropsychiatric conditions. We analyzed rare CNVs in Tourette syndrome (TS) to identify novel risk regions and relevant pathways, to evaluate burden of structural variation in cases versus controls, and to assess overlap of identified variations with those in other neuropsychiatric syndromes.<h4>Methods</h4>We conducted a case-control study of 460 individuals with TS, including  ...[more]

Similar Datasets

| S-EPMC5568251 | biostudies-literature
| S-EPMC2876824 | biostudies-other
| S-EPMC3380845 | biostudies-other
| S-EPMC4118997 | biostudies-literature
| S-EPMC5607249 | biostudies-literature
| S-EPMC3720840 | biostudies-literature
| S-EPMC4773219 | biostudies-literature
| S-EPMC6205289 | biostudies-literature
| S-EPMC5803418 | biostudies-literature
| S-EPMC7443120 | biostudies-literature